Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCTR20250309002Phase 1Not yet recruiting
Phase 1, randomised, open-label trial of ethinyl estradiol + drospirenone, ethinyl estradiol and drospirenone in Not applicable (2 arms), sponsored by Pharmacy Service Center, Faculty of Pharmacy, Chiang Mai University. Primary endpoints: Ethinyl estradiol AUC0-t, Ethinyl estradiol AUC0-inf and 3 more. Planned start Jun 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on TCTR20250309002.